Issue #74 • January 27, 2026
Hi Seedradar Squad! This week, the focus shifted from "training" models to "running" them as Baseten secured a massive Series E to own the high-performance inference layer.
Simultaneously, the interface wars heated up as Anthropic connected Claude directly to Slack and Figma, turning the chat window into an action-capable command center. Plus, we deep dive into Doctronic, a USV-backed startup that isn't just giving advice—it is the first "AI Doctor" authorized to write prescriptions autonomously.
📈 Important News of the Week!
• Baseten raised $300 million in a Series E round valued at $5 billion. The company’s platform helps enterprises run high-performance AI inference, a market that has seen demand explode as companies move from training models to deploying them. - Read More
• Anthropic has integrated popular workplace tools like Slack, Figma, and Canva directly into its Claude chatbot interface. This update allows enterprise users to perform actions—like sending messages or editing designs—within the chat, positioning Claude as a central hub for daily workflows. - Read More
• Corxel Pharmaceuticals secured $287 million in Series D1 funding to advance its cardiometabolic pipeline. The funds will support the development of its lead candidate, a small molecule GLP-1 receptor agonist, highlighting the continued investor frenzy around weight-loss and metabolic drugs. - Read More
• Microsoft unveiled a new custom silicon chip designed specifically to accelerate AI inference workloads for Azure customers. The chip aims to reduce the cost and latency of running large models, reducing reliance on Nvidia GPUs and strengthening Microsoft's vertical integration stack. - Read More
• Harvey has acquired Hexus, a startup specializing in AI-generated product demos and documentation. The acquisition is a strategic move to enhance Harvey's ability to demonstrate its complex legal workflows and consolidate its dominance in the competitive legal AI market. - Read More
🌱 The Next Big Thing: Our Startup Pick!
🎯 This Week's Emerging Star: Doctronic
Doctronic, a Union Square Ventures-backed startup, is redefining primary care as the world's first fully integrated "AI Doctor." The company uses a proprietary multi-agent system to triage symptoms with over 99% clinical accuracy, offering free, anonymous consultations that can seamlessly escalate to licensed human physicians for video visits and prescriptions in minutes.
By bridging the gap between unreliable web searches and expensive urgent care, Doctronic's hybrid model provides instant, medical-grade guidance 24/7. Its recent regulatory approval to autonomously handle prescription renewals in Utah positions it as a pioneer in AI-driven healthcare delivery, making it a startup to watch very closely.
🔥 Igniting the Future: Seedradar Ventures Syndicate!
At Seedradar Ventures, we back relentless founders at the earliest stage, investing in teams solving big problems with solutions that deliver a 10–20x greater impact.
Our syndicate offers investors access to a curated pipeline of early-stage startups, sourced through our network.
🚀 Startup Radar: Movers, Shakers & Future Makers
|
🛠️ Trending AI Tools to Supercharge Your Workflow!
|
💼 Join the Revolution: Hot Startup Jobs!
|
💼 Resource of the Week!
📊 2026 Data Privacy Benchmark Study
Cisco's annual report providing crucial metrics on GenAI privacy spending and trust, serving as a strategic benchmark for B2B AI startups selling to enterprise.
🔎 Powered by Seedradar Ventures
Disclosure: Seedradar Ventures and/or its general partner may hold investments in some of the companies mentioned in this newsletter. This content is provided for informational purposes only and should not be considered investment advice.
